1044 Validation of the Treatment-Induced Neuropathy Assessment Scale (TNAS) in Chinese Cancer Patients: a prospective cohort study Chenxi He 1 , Wei Xu 1 , Feng Gao 2 , Wenlin Wu 1 , Shi Wang 1 , Qiuling Shi 1 , Fan Li 1 1 Chongqing Medical University, Chongqing, China, 2 Mianyang Central Hospital, Mianyang, China Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1044 Aims Treatment-induced peripheral neuropathy(TIPN) is a critical adverse effect of Anti-tumor treatment
Klinic will stay informed about the latest developments and be ready to guide you when retatrutide becomes accessible
Growth hormone creates the ideal environment for muscle growth
The $69/month that headlines the ads is just the membership fee for branded medications, not a GLP-1 medication plan